Max Chat
Sun Pharma Advanced Research Company Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 56.1 | -100% | 0 | 0% |
| P/S |
|
161.07 | 17.81 | 804.58% |
|
|
| P/BV |
|
96.76 | 8.11 | 1093.79% |
|
|
| P/FCF |
|
-13.75 | -381.81 | -96.4% |
|
|
| Ev/Ebitda |
|
-45.73 | 4.22 | -1184.92% |
|
|
| Ev/S |
|
161.62 | 13.93 | 1060.58% |
|
|
| Ev/FCF |
|
-26.79 | -323.67 | -91.72% |
|
|
| E/P |
|
-0.0618 | 0.0159 | -488.29% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-268.95 | -32.77 | 720.74% | -186.03 | +44.57% |
| ROE |
|
-121.28 | 3.58 | -3487.04% |
|
|
| ROA |
|
-57.57 | 3.38 | -1803.62% |
|
|
| ROIC |
|
0 | 13.38 | -100% |
|
|
| ROS |
|
-512.56 | -47.93 | 969.35% |
|
|
| ROCE |
|
-177.85 | -3.43 | 5081.51% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0771 | -0.571 | -86.49% | -0.4429 | -82.58% |
| Nеt Debt/Ebitda |
|
-0.2051 | -0.2949 | -30.46% |
|
|
| Debt/Ratio |
|
0.0304 | 0.1259 | -75.84% |
|
|
| Debt/Equity |
|
3.1 | 0.6988 | 343.01% |
|
|
| Debt/Net Income |
|
-0.0405 | 1.67 | -102.42% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.6581 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.68 | -100% | ||
| DSI |
|
0 | 0.8171 | -100% |
|
|
| Average dividend growth |
|
0 | 0.8603 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.8821 | -100% |
|
|
| Average percentage for payments |
|
0 | 22.22 | -100% |
|
|
| Difference from average difference in sector |
|
-0.6581 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-1.65 | -56.75 | -97.09% | ||
| Growth impulse Ebitda in 5 years |
|
47.46 | 72.97 | -34.96% | ||
| Growth impulse Net Income in 5 years |
|
23.95 | -47.69 | -150.22% | ||
| Growth impulse FCF in 5 years |
|
72.06 | -112.83 | -163.87% | ||
| Growth impulse EPS in 5 years |
|
0.0867 | -32.16 | -100.27% |
IP Score
2.92/10
